UniSuper Management Pty Ltd Has $2.04 Million Stock Holdings in Align Technology, Inc. $ALGN

UniSuper Management Pty Ltd boosted its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 48.5% in the third quarter, Holdings Channel reports. The firm owned 16,298 shares of the medical equipment provider’s stock after purchasing an additional 5,326 shares during the period. UniSuper Management Pty Ltd’s holdings in Align Technology were worth $2,041,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Rothschild Investment LLC boosted its position in shares of Align Technology by 140.3% during the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares in the last quarter. True Wealth Design LLC raised its stake in Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 153 shares during the period. Cromwell Holdings LLC raised its stake in Align Technology by 2,900.0% during the 2nd quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 174 shares during the period. CYBER HORNET ETFs LLC bought a new position in Align Technology during the second quarter worth about $36,000. Finally, MUFG Securities EMEA plc acquired a new position in Align Technology in the second quarter valued at about $38,000. Institutional investors own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALGN. Jefferies Financial Group lifted their price objective on Align Technology from $140.00 to $155.00 in a report on Thursday, October 30th. Stifel Nicolaus set a $200.00 price target on shares of Align Technology in a research note on Thursday, October 30th. Weiss Ratings raised shares of Align Technology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 16th. Needham & Company LLC restated a “hold” rating on shares of Align Technology in a report on Thursday, October 30th. Finally, Morgan Stanley upped their target price on shares of Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $176.82.

Align Technology Trading Down 0.4%

Align Technology stock opened at $167.04 on Wednesday. Align Technology, Inc. has a 1-year low of $122.00 and a 1-year high of $232.20. The company has a fifty day simple moving average of $159.35 and a 200 day simple moving average of $149.57. The company has a market cap of $11.99 billion, a P/E ratio of 32.37, a price-to-earnings-growth ratio of 1.88 and a beta of 1.83.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. The company’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.35 EPS. On average, equities research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.